| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM447439 is a small molecule inhibitor that directly targets BUBR1. It inhibits the kinase activity of BUBR1, preventing its phosphorylation of substrates. This direct inhibition disrupts the mitotic checkpoint, leading to aberrant cell division and genomic instability. | ||||||
TAK-960 | 1137868-52-0 | sc-364631 sc-364631A | 5 mg 10 mg | $316.00 $666.00 | 1 | |
TAK-960 is a potent Aurora A kinase inhibitor that indirectly affects BUBR1. By inhibiting Aurora A, TAK-960 disrupts the SAC and influences BUBR1-mediated signaling pathways during mitosis. | ||||||
Reversine | 656820-32-5 | sc-203236 | 5 mg | $221.00 | 13 | |
Reversine is a small molecule that indirectly influences BUBR1 by inhibiting Aurora B kinase. By disrupting Aurora B activity, Reversine affects the SAC and leads to altered BUBR1-mediated signaling pathways during mitosis. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
S-Trityl-L-cysteine is an inhibitor of the mitotic kinesin Eg5, indirectly affecting BUBR1 by disrupting spindle assembly. By inhibiting Eg5, S-Trityl-L-cysteine induces mitotic arrest and activates the SAC, influencing BUBR1-mediated signaling pathways. | ||||||
BI 2536 | 755038-02-9 | sc-364431 sc-364431A | 5 mg 50 mg | $151.00 $525.00 | 8 | |
BI 2536 is a potent PLK1 inhibitor that indirectly modulates BUBR1 activity. By inhibiting PLK1, BI 2536 disrupts the SAC and influences BUBR1-mediated signaling pathways during mitosis. | ||||||